Abstract:Objective To explore the possibility of in vivo molecular imaging with MR in the nude mouse model implanted with breast cancer using specific contrast agents,and to evaluate the diagnostic value for breast cancer. Methods The specific contrast agent Gd-DTPA-BSA-chTNT was obtained by conjugating Gd-DTPA-BSA and monoclonal antibody of chTNT under specific conditions.The breast cancer cells of MDA-MB-231 were orthotopically implanted in the five-week-old BALB/c female nude mice(class SPF)to establish the animal model.Twelve nude mice with human breast cancer were randomly divided into the experimental group(n=6)and the control group(n=6).The animals in the experi- mental group were injected with Gd-DTPA-BSA-chTNT via vena caudalis,whereas the routine Gd-DTPA was used in the control group at the same dosage of gadolinium with the same amount of 0.2 ml as the experimental group.The tumor sig- nal intensities(SI)on T1WI were measured at 5 min,1 h,2 h,3h,4h,8 h,12 h and 24 h respectively after injection of contrast agents with the SI of the anterior limb muscles on the same side as control,and then all of the results were statis- tically analyzed.The CNR(contrast to noise ratio)was calculated as well.Results The tumor SI increased remarkably in the experimental group at 1 hour after injection of Gd-DTPA-BSA-chTNT,reached the peak at 4 h,and enhanced persis- tently for more than 24 h.There was a statistical difference on the SI in the experimental group before and after injection of the specific contrast agents(P＜0.001).The SI of the muscles did not increased obviously in all the time and no statisti- cal difference between precontrast and postcontrast imaging(P＞0.05).In comparison with the precontrast imaging,the SI of tumor and muscles in the control group increased greatly at 5 min,1 h,2 h,3 h and 4 h respectively after injection of Gd-DTPA with significant difference(P＜0.001)between the images with and without contrast.And the contrast in the tumors almost entirely washed out at 8 h after injection of Gd-DTPA.Conclusions The in vivo MR imaging investigation of breast cancer in the nude mouse model could be realized by employing the specific contrast agents Gd-DTPA-BSA- chTNT in this study.The contrast agent shows the definite characteristics of tumor targeting effect on human breast cancer orthotopically implanted in the nude mice,and therefore the imaging will be potentially conducive to the detection and characterization of breast cancer.

Application of Optical in Vivo Imaging Combined with MRI in Diagnosis of Lung Carcinoma-bearing Mice

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Application of 3.0T-MRI DWI in evaluating the efficacy of synchronous radiotherapy and chemotherapy for advanced lung cancer

Dynamic Contrast-Enhanced Computed Tomography Functional Imaging for the Evaluation of Tumor Angiogenesis in Patients with Lung Carcinoma

Dynamic Observation of in Vivo Biofluorescence Imaging in Nude Mouse Model of Human Lung Carcinoma

Application of Epithelial Growth Factor Receptor-Targeted Magnetic Resonance Imaging and Near-Infrared II Dual-Modal Probe in Lung Cancer Diagnosis and Surgical Resection

Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma

Value of Dynamic MRI in Monitoring the Microenvironmental Changes of Anti-Vascular Therapy in a Xenograft Model

In Vivo Tomographic Imaging of Lung Colonization of Tumour in Mouse with Simultaneous Fluorescence and X‐ray CT

Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis - An animal experimental prospective cohort study

Application of an indocyanine green-mediated fluorescence imaging navigation system in detecting mice tumors

Combined Bioluminescence and Fluorescence Imaging Visualizing Orthotopic Lung Adenocarcinoma Xenograft in Vivo.

In Vivo Near-Infrared Fluorescence Imaging of CD105 Expression During Tumor Angiogenesis

Initial Experience of Correlating Diffusion Spectral Parameters with Histopathologic Indexes in Murine Colorectal Tumor Homografts

In vivo validation of dual-modality system for simultaneous positron emission tomography and optical tomographic imaging

Intraoperative Identification and Guidance of Breast Cancer Microfoci Using Ultrasound and Near-Infrared Fluorescence Dual-Modality Imaging

In Vivo Photoacoustic Molecular Imaging of Breast Carcinoma with Folate Receptor-Targeted Indocyanine Green Nanoprobes

Highly Sensitive Fluorescence and Photoacoustic Detection of Metastatic Breast Cancer in Mice Using Dual-Modal Nanoprobes

In vivo long-term investigation of tumor bearing mKate2 by an in-house fluorescence molecular imaging system

Experimental Study on H22 Hepatocarcinoma Transplanted Model in Mice by MR Diffusion Weighted Imaging Combined with Laboratory Examination

Development of a New Specific MR Contrast Agent Gd-DTPA-BSA-chTNT and Its Application in Vivo Molecular MR Imaging in the Nude Mouse Model Implanted with Human Breast Cancer